Treatment of chondrosarcoma cells with the selective PPARγ ligand pioglitazone or 15d-PGJ2 also inhibited their proliferation and induced apoptosis in a dose-dependent manner [24]. The gene discussed is PPARG; the disease is chondrosarcoma.